A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study
OPEN Applied health economics and health policy | 7 Dec 2018
M Touat, M Opatowski, C Brun-Buisson, K Cosker, D Guillemot, J Salomon, P Tuppin, G de Lagasnerie and L Watier
Antimicrobial resistance (AMR) has become one of the biggest threats to global public health given its association with mortality, morbidity and cost of health care. However, little is known on the economic burden of hospitalization attributable to AMR from a public health insurance perspective. We assessed the excess costs to the French public health insurance system attributable to AMR infections in hospitals.
* Data courtesy of Altmetric.com